We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Heiq Plc | LSE:HEIQ | London | Ordinary Share | GB00BN2CJ299 | ORD GBP0.05 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.22 | -2.46% | 8.74 | 8.60 | 8.88 | 8.70 | 8.62 | 8.62 | 33,590 | 16:35:04 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Finance Services | 48.1M | -29.25M | -0.2081 | -0.42 | 12.23M |
Date | Subject | Author | Discuss |
---|---|---|---|
23/1/2021 22:14 | ChateauMuser, most who've been investing for any length of time view Leon Boros as a serious investor who's thought of as a straight guy. Sorry to say but I can't give your gripes any credibility when I see you've only registered on ADVFN today. | dibbs | |
23/1/2021 21:09 | You going to give HEIQ a tarnishing name with spivvy pumps. How did Boro get his share in the placing - was he given them to pump them? a quid pro quo? Suspect when it reverses in a shell. | chateaumusar | |
23/1/2021 21:06 | If someone provides detailed research and outlines the pros and cons of a particular investment that is not pumping anything! If any poster were to shout from the rooftops that a company is going to double its share price by Wednesday and not offering any analysis then that is pumping. I think investors know the difference. | davidosh | |
23/1/2021 20:59 | @Davidosh Before presenting he should indicate his trades in HEIQ since IPO and list all of them imho. He pumped it at the last mello. | chateaumusar | |
23/1/2021 20:22 | CM....Leon cannot be accused of ramping. He did a lot of research before he mentioned them at our Christmas Mello and they have nearly doubled since then. I think we know who the rampers are around BBs and Leon is not one of them. You can be sure Leon holds shares in the company as he already declared that over a month ago. Mello is not a pumping station and you only have to watch the BASH session to know we are very critical or Skeptical of some companies. Anyway the MelloMonday evening shows are watched by thousands and so long as investors find them useful and enjoyable in these times of lockdown then the community will thrive. | davidosh | |
23/1/2021 19:16 | EI yes, have you seen the presentation on Investor meet? There's also the prospectus and a broker note out or perhaps just tune into the Mello presentation on Monday. Revenues were projected at $43m for 2020 and profits at $8m for the year but they did $30m in H1 with big growth in profits from their viroblock fabric. Superg not sure what you're on about. You may have a point about virus protection but HEIQ produce viroblock fabric (amongst other fabrics) which can be found in products made by others (and themselves) eg | homebrewruss | |
23/1/2021 19:07 | @Davidosh All rather odd for a PI to be presenting the company. Has it not got advisors> LB has already pumped it precious Has Leon Boro got 500,000 shares in the placing that he will dump? Will he declare his position to ensure that Mello is not a pumping station please | chateaumusar | |
23/1/2021 18:58 | Is this company profitable?. | essentialinvestor | |
23/1/2021 18:44 | Hi Apologies I have just become aware of this but want to make a point as it's serious and a potential serious misread by some. As I understand it the mask here being talk about is Type IIR. DO NOT WEAR SUCH MASKS IF YOU WANT TO BE PROTECTED FROM COVID OR OTHER VIRUSES. In Hospitals they are the blue/white type, they are splash type protectors and help protect others form the wearer. THEY DO NOT PROTECT THE WEARER FRIOM VIRUSES. SO please DO NOT buy such masks thinking they will protect you form breathing in the virus. NHS guidance Type I, I R, II and II R face masks are medical masks tested in the direction of exhalation (inside to outside) Type II face masks (EN14683) are medical face masks They are not effective at protecting the wearer from airbourne diseases such as coronavirus. If you are pumping type II R as a mask that protects the wearer then you are putting lives at risk as some may think it will protect them. | superg1 | |
22/1/2021 02:05 | Yes totally correct there will be a presentation by HeiQ at the Mello evening show on Monday 25th January. There are a number of quality presentations including Lord Lee on takeovers and how P.Is miss out. There will be three companies presenting and this will be the first time HeiQ have presented at Mello as they only came to the market three months ago so we are giving them the full 40 minutes and there will be 15 minutes for Q&A so lots of opportunity to take your questions. You may also enjoy the MelloBASH (Buy, Avoid, Sell or Hold) which is unique to Mello and allows a panel of analysts, professional investors and fund managers to give their measured and researched thoughts on a number of listed companies If you would like a half price ticket to join the other 600 investors then just enter the code MMTADVFN50 when purchasing your ticket. | davidosh | |
21/1/2021 12:18 | HEIQ being introduced by Leon Boros | melody9999 | |
19/1/2021 10:00 | Be nice if this was another company like Avon Rubber -AVON . Started off at two pound a share . | 2bluelynn | |
18/1/2021 20:03 | HeiQ is a pioneer and at the forefront of global technology in the $10 billion antimicrobial fabrics and $24 billion textile chemicals market. With the focus on materials and textile innovation, HeiQ has created some of the most effective, durable and high-performance technologies and textile effects in the market today, which cool, warm, dry, repel, purify, and destroy viruses. Since 2005, HeiQ has developed over 200 technologies in partnership with 300 major brands. HeiQ is a high intellectual capital company which has successfully built up a reputation in textile technologies, having won multiple awards and innovating with leading eco-conscious brands such as Patagonia. Led by an experienced management team, HeiQ rapidly researches new solutions for partners, quickly delivers scaled up manufacturing from its sites across the world and helps partners market the product to end consumers – aiming for lab to consumer in months. HeiQ aims to deliver growth for its shareholders through a combination of increased sales of its core products and by entering additional lucrative markets through disruptive innovations. | jammytass | |
18/1/2021 20:01 | nice rise well done to all | jammytass | |
18/1/2021 14:36 | Let mine go as see possible turn on the chart spanning 15-18/1/2021 | bamboo2 | |
18/1/2021 10:18 | HEIQ has taken off today !😃 | masurenguy | |
14/1/2021 13:00 | Today's Shares Magazine profiles a handful of Fund Managers and asks for their top pick for 2021, 2 of whom choose HEIQ. Miles Nolan of MI Sterling Select Companies - "The UK market has few globally scalable businesses which enjoy high margins and we welcome HeiQ to the portfolio". Anna Macdonald of TB Amati UK Smaller Companies Fund - "despite a strong performance in the share price so far, we remain enthused about the opportunity for what is now our largest holding". | sranmal | |
14/1/2021 12:44 | Looks like HEIQ are presenting at the next Mello event on the 25h Jan: | homebrewruss | |
14/1/2021 09:15 | Hi Mas, As you know, the prior gap filled yesterday. This now becomes the support zone. [183-189]. First resistance is 210 then 250 Initial target is to test the high at 250. Eod close above 250, within a limited time frame, confirms a HT Flag with a tp approx 315.4 | bamboo2 | |
14/1/2021 08:50 | Bought in this morning. Chart looking good too | essential | |
14/1/2021 08:32 | A good anti Covid play | nw99 | |
14/1/2021 08:21 | Hi bamboo2, good to see you here - I took an initial position this morning. | masurenguy | |
14/1/2021 08:17 | SCSW likes this have bought | nw99 | |
13/1/2021 23:04 | I think it's very likely that the current revenue forecasts for 2020 ($43m) will be beaten. Perhaps somewhere just over $50m is likely however that does assume that much of the viroblock sales in H1 have continued into H2 and there aren't piles of the stuff stuck with retailers. Looking around via Google though there do seem to be a fair number of suppliers launching viroblock ranges in October etc so that seems promising for continuing orders in H2. The question will then be if they can keep the momentum going forward. I'm hopeful that they can achieve continued growth towards their stated revenue goals but let's wait and see the outlook in the next results. | homebrewruss |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions